Related Experiment Videos

Identification of PML oncogenic domains (PODs) in human megakaryocytes

A Drouin1, A Schmitt, J M Massé

  • 1Institut Cochin de Génétique Moléculaire, INSERM U. 474, Paris, France.

Experimental Cell Research
|November 22, 2001
PubMed

Insights

PML oncogenic domains (PODs) were identified in human megakaryocytes (Mks). Their numbers increase with nuclear lobularity and ploidy during megakaryocyte development.

Area of Science:

  • Cell Biology
  • Nuclear Structure
  • Hematopoiesis

Background:

  • Megakaryocytes (Mks) possess unique polyploid nuclei.
  • PML oncogenic domains (PODs) are nuclear subdomains found in various eukaryotic cells.
  • PODs are typically characterized by PML and Sp 100 antigens, appearing as speckled dots.

Purpose of the Study:

  • To investigate the presence and ultrastructure of PODs in megakaryocytic lineage cells.
  • To determine the relationship between PODs and megakaryocyte nuclear morphology, specifically ploidy and lobularity.

Main Methods:

  • Indirect immunofluorescence (IF) and immunoelectron microscopy (IEM) were employed.
  • Antibodies against PML, Sp 100, and anti-nuclear dots were used for labeling.
  • HEL cell line and human cultured Mks were utilized for the study.

Main Results:

  • PODs were successfully identified in both HEL cells and human Mks at the ultrastructural level.
  • The number of PODs was found to increase proportionally with nuclear lobularity in Mks.
  • A parallel increase in PODs number was observed with megakaryocyte ploidy.

Conclusions:

  • This study reports the ultrastructural identification of PODs in human megakaryocytes.
  • Megakaryocyte endomitosis leads to not only DNA increase but also the multiplication of nuclear structures like PODs.
  • PODs are dynamic nuclear components that expand with megakaryocyte ploidy and nuclear complexity.

Related Concept Videos